US$ 22.70
glp 1 agonist weight loss mechanism GLP-1 Agonists For Obesity In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH List of GLP-1 Receptor Agonists
Description
Pancreatitis: Though rare, there is a potential risk of pancreatitis, a serious condition involving inflammation of the pancreas

GLP-1RAs, which achieved great success in 2023 and draws peoples attention back to obesity treatments and GLP-1 therapies worldwide, was chosen as the breakthrough of year 2023 by Science [2]

& Burne, T

In mice, both acute and chronic central administration of exendin-4 increases HR and BP with concomitant decrease in excitatory glutamatergic and inhibitory glycinergic neurotransmission to preganglionic parasympathetic cardiac vagal neurons

2 Wilcoxon rank sum test

GLP-1 medications work by mimicking the naturally occurring hormone GLP-1, leading to improved blood sugar control and reduced appetite
